相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The long and winding road: stem cells for cystic fibrosis
Massimo Conese et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
Gizem Osman et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Detection of CFTR function and modulation in primary human nasal cell spheroids
John J. Brewington et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Translational research to enable personalized treatment of cystic fibrosis
Marne C. Hagemeijer et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis
Xueqing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
Steven E. Van der Plas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Guido Veit et al.
NATURE MEDICINE (2018)
Induced pluripotent stem cells for treating cystic fibrosis: State of the science
Bette S. Pollard et al.
PEDIATRIC PULMONOLOGY (2018)
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Dominic Keating et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
J. C. Davies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
Iwona Pranke et al.
ERJ OPEN RESEARCH (2018)
Human Bocavirus Type-1 Capsid Facilitates the Transduction of Ferret Airways by Adeno-Associated Virus Genomes
Ziying Yan et al.
HUMAN GENE THERAPY (2017)
The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis
Anne Bergougnoux et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
CRISPR Editing Technology in Biological and Biomedical Investigation
Martyn K. White et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice
Jeff R. Crosby et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR
Scott H. Donaldson et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor
Meredith C. Fidler et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
A common mechanism for CFTR potentiators
Han-I Yeh et al.
JOURNAL OF GENERAL PHYSIOLOGY (2017)
Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Steven M. Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhaled Drug Therapy 2016: The Year in Review
Rajiv Dhand
RESPIRATORY CARE (2017)
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
Iwona M. Pranke et al.
SCIENTIFIC REPORTS (2017)
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled, phase 3 trial
Felix Ratjen et al.
LANCET RESPIRATORY MEDICINE (2017)
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study
Michael W. Konstan et al.
LANCET RESPIRATORY MEDICINE (2017)
Generation of Induced Progenitor-like Cells from Mature Epithelial Cells Using Interrupted Reprogramming
Li Guo et al.
STEM CELL REPORTS (2017)
Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA
David J. Sanz et al.
PLOS ONE (2017)
Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks
Ulrich Martin
FRONTIERS IN MEDICINE (2017)
Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties
Angelique Mottais et al.
BIOSCIENCE REPORTS (2017)
Nasospheroids permit measurements of CFTR-dependent fluid transport
Jennifer S. Guimbellot et al.
JCI INSIGHT (2017)
Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue
Steven V. Molinski et al.
EMBO MOLECULAR MEDICINE (2017)
Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR
Tip W. Loo et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Genetic therapies for cystic fibrosis lung disease
Stephen L. Hart et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Gene Editing and Genetic Lung Disease Basic Research Meets Therapeutic Application
Deepthi Alapati et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides
Susana Igreja et al.
HUMAN MUTATION (2016)
Augmentation of CFTR maturation by S-nitrosoglutathione reductase
Khalequz Zaman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770
Martina Gentzsch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
rAAV-CFTRAR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice
Dragana Vidovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
Maximilian W. Popp et al.
CELL (2016)
Cystic fibrosis: a model system for precision medicine
Stacey L. Martiniano et al.
CURRENT OPINION IN PEDIATRICS (2016)
EPAC1 activation by cAMP stabilizes CFTR at the membrane by promoting its interaction with NHERF1
Miguel J. Lobo et al.
JOURNAL OF CELL SCIENCE (2016)
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
Marianna Foldvari et al.
JOURNAL OF CONTROLLED RELEASE (2016)
32 Properties of a novel F508del-CFTR corrector FDL169
M. Zawistoski et al.
Journal of Cystic Fibrosis (2016)
Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ΔF508CFTR Dysfunction: Impact in Cystic Fibrosis
Grazyna Faure et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
Johanna F. Dekkers et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene
Jennifer A. Hollywood et al.
SCIENTIFIC REPORTS (2016)
Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells
Senem Simsek et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
BeLa Z. Schmidt et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2016)
Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry
Chandrima Sinha et al.
CHEMBIOCHEM (2015)
CFTR Inactivation by Lentiviral Vector-mediated RNA Interference and CRISPR-Cas9 Genome Editing in Human Airway Epithelial Cells
Jessica Bellec et al.
CURRENT GENE THERAPY (2015)
Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors
Ling Li et al.
HUMAN GENE THERAPY (2015)
Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del/R117H/IVS8-5T
S. Carter et al.
Journal of Cystic Fibrosis (2015)
Origins of Cystic Fibrosis Lung Disease
David A. Stoltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Abdul Rehman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Inflammation and its genesis in cystic fibrosis
David P. Nichols et al.
PEDIATRIC PULMONOLOGY (2015)
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy
Panagiotis Mastorakos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs
Amy L. Firth et al.
CELL REPORTS (2015)
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W. F. W. Alton et al.
LANCET RESPIRATORY MEDICINE (2015)
Targeted Correction and Restored Function of the CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells
Ana M. Crane et al.
STEM CELL REPORTS (2015)
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
Nikhil T. Awatade et al.
EBIOMEDICINE (2015)
Increased efficacy of VX-809 in different cellular systems results from an early stabilization effect of F508del-CFTR
Carlos M. Farinha et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
An Official American Thoracic Society Workshop Report: Stem Cells and Cell Therapies in Lung Biology and Diseases
Daniel J. Weiss et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
Xiaojiao Xue et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface
Paul D. W. Eckford et al.
CHEMISTRY & BIOLOGY (2014)
Biosafety of Recombinant Adeno-associated Virus Vectors
David Dismuke et al.
CURRENT GENE THERAPY (2014)
Biosynthesis of cystic fibrosis transmembrane conductance regulator
Iwona M. Pranke et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
The relative frequency of CFTR mutation classes in European patients with cystic fibrosis
K. De Boeck et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Functional architecture of the CFTR chloride channel
Paul Linsdell
MOLECULAR MEMBRANE BIOLOGY (2014)
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Guido Veit et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Deborah M. Cholon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Mechanisms of CFTR Functional Variants That Impair Regulated Bicarbonate Permeation and Increase Risk for Pancreatitis but Not for Cystic Fibrosis
Jessica LaRusch et al.
PLOS GENETICS (2014)
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Elton Kerem et al.
LANCET RESPIRATORY MEDICINE (2014)
HGF Stimulation of Rac1 Signaling Enhances Pharmacological Correction of the Most Prevalent Cystic Fibrosis Mutant F508del-CFTR
Sonia Moniz et al.
ACS CHEMICAL BIOLOGY (2013)
Corrector VX-809 stabilizes the first transmembrane domain of CFTR
Tip W. Loo et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
Gerald Schwank et al.
CELL STEM CELL (2013)
Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
Carlos M. Farinha et al.
CHEMISTRY & BIOLOGY (2013)
Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
Norbert Odolczyk et al.
EMBO MOLECULAR MEDICINE (2013)
Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein
Lihua He et al.
FASEB JOURNAL (2013)
CFTR: Effect of ICL2 and ICL4 amino acids in close spatial proximity on the current properties of the channel
Arnaud Billet et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy
Nadine Bangel-Ruland et al.
JOURNAL OF GENE MEDICINE (2013)
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Johanna F. Dekkers et al.
NATURE MEDICINE (2013)
Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle
Kang-Yang Jih et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Endogenous Lung Regeneration Potential and Limitations
Jason Rock et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
Patrick A. Flume et al.
CHEST (2012)
mRNA as a Versatile Tool for Exogenous Protein Expression
Andreas N. Kuhn et al.
CURRENT GENE THERAPY (2012)
Supercoiled Minivector DNA resists shear forces associated with gene therapy delivery
D. J. Catanese et al.
GENE THERAPY (2012)
Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect
Julien Colas et al.
HUMAN MOLECULAR GENETICS (2012)
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
Paul D. W. Eckford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ivacaftor potentiation of multiple CFTR channels with gating mutations
Haihui Yu et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations
Jeyakumar Kandasamy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell
Shiro Yui et al.
NATURE MEDICINE (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
CFTR: folding, misfolding and correcting the ΔF508 conformational defect
Gergely L. Lukacs et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators
Louise C. Pyle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
Heidi M. Sampson et al.
CHEMISTRY & BIOLOGY (2011)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M. Wilschanski et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Cystic Fibrosis: A New Target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines
Roberta Budriesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
Steven M. Rowe et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis
Peter A. Sloane et al.
CURRENT OPINION IN PULMONARY MEDICINE (2010)
Potentiation of Disease-associated Cystic Fibrosis Transmembrane Conductance Regulator Mutants by Hydrolyzable ATP Analogs
Haruna Miki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
Patrick H. Thibodeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening
Ori Kalid et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Rescue of the protein folding defect in cystic fibrosis in vitro by the investigational small molecule, VX-809
F. Van Goor et al.
Journal of Cystic Fibrosis (2010)
Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2010)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M. Hutt et al.
NATURE CHEMICAL BIOLOGY (2010)
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Frank J. Accurso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy
Nadzeya V. Marozkina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung
Jonathan L. McQualter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Cystic Fibrosis Respiratory Epithelial Cell Chronically Treated by Miglustat Acquires a Non-Cystic Fibrosis-Like Phenotype
Caroline Norez et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease
Stan Pasyk et al.
BIOCHEMICAL JOURNAL (2009)
Correctors Enhance Maturation of ΔF508 CFTR by Promoting Interactions between the Two Halves of the Molecule
Tip W. Loo et al.
BIOCHEMISTRY (2009)
Deletion of CFTR Translation Start Site Reveals Functional Isoforms of the Protein in CF Patients
Anabela S. Ramalho et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects
L. A. Pringle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
Igor Nudelman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Rescue of Functional F508del Cystic Fibrosis Transmembrane Conductance Regulator by Vasoactive Intestinal Peptide in the Human Nasal Epithelial Cell Line JME/CF15
Sara Rafferty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation
Tzyh-Chang Hwang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
A Small-Molecule Modulator Interacts Directly with Delta Phe508-CFTR to Modify Its ATPase Activity and Conformational Stability
Leigh Wellhauser et al.
MOLECULAR PHARMACOLOGY (2009)
ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator
Daniella Muallem et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis
Bob Lubamba et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
CFTR function and prospects for therapy
John R. Riordan
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Correctors promote folding of the CFTR in the endoplasmic reticulum
Tip W. Loo et al.
BIOCHEMICAL JOURNAL (2008)
Potent s-cis-locked bithiazole correctors of ΔF508 cystic fibrosis transmembrane conductance regulator cellular processing for cystic fibrosis therapy
Gui Jun Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells
Sabrina Noel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog
Silvia G. Bompadre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2008)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis:: a pilot study
Isabelle Sermet-Gaudelus et al.
BMC MEDICINE (2007)
Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains
Wei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Induction of pluripotent stem cells from fibroblast cultures
Kazutoshi Takahashi et al.
NATURE PROTOCOLS (2007)
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis
Xiaodong Wang et al.
CELL (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Rescue of ΔF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin:: Involvement of the keratin 18 network
J Lipecka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel
ZW Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High affinity ATP/ADP analogues as new tools for studying CFTR gating
Z Zhou et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effect of jet nebulization on DNA: identifying the dominant degradation mechanism and mitigation methods
YK Lentz et al.
JOURNAL OF AEROSOL SCIENCE (2005)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phenylglycine and sulfonamide correctors of defective ΔF508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating
N Pedemonte et al.
MOLECULAR PHARMACOLOGY (2005)
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains
P Vergani et al.
NATURE (2005)
Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity
AL Berger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
K Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects
ME Egan et al.
SCIENCE (2004)
Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes
M Sharma et al.
JOURNAL OF CELL BIOLOGY (2004)
Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics
LE Maquat
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Reversal of cystic fibrosis phenotype in a cultured Δ508 cystic fibrosis transmembrane conductance regulator cell line by oligonucleotide insertion
PC Zamecnik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines
K Varga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nanomolar affinity small molecule correctors of defective ΔF508-CFTR chloride channel gating
H Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo
LG Gregory et al.
MOLECULAR THERAPY (2003)
Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate
PL Zeitlin et al.
MOLECULAR THERAPY (2002)
Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis
AA Aleksandrov et al.
FEBS LETTERS (2002)
A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator
MS Gelman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions
BG Harvey et al.
HUMAN GENE THERAPY (2002)
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications
PM Joseph et al.
HUMAN GENE THERAPY (2001)
Sodium 4-phenylbutyrate downregulates Hsc70:: implications for intracellular trafficking of ΔF508-CFTR
RC Rubenstein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations
M Wilschanski et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
